Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 141 articles:
HTML format



Single Articles


    July 2022
  1. LI J, Zhen Z, Huang P, Dong YG, et al
    Salt restriction and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Heart. 2022 Jul 18. pii: heartjnl-2022-321167. doi: 10.1136/heartjnl-2022-321167
    PubMed     Abstract available


  2. BELZILE D, Senechal M
    Microstructure: a potential path to elucidate sex-specific pathological mechanisms in heart failure?
    Heart. 2022 Jul 14. pii: heartjnl-2022-321250. doi: 10.1136/heartjnl-2022-321250
    PubMed    


  3. OTTO CM
    Heartbeat: cardiac resynchronisation therapy pacemaker or defibrillator in patients with heart failure with reduced ejection fraction?
    Heart. 2022;108:1161-1163.
    PubMed    


  4. MAILLE B, Bodin A, Bisson A, Herbert J, et al
    Predicting outcome after cardiac resynchronisation therapy defibrillator implantation: the cardiac resynchronisation therapy defibrillator Futility score.
    Heart. 2022;108:1186-1193.
    PubMed     Abstract available


  5. STRAW S, Mullens W, Witte KK
    Cardiac resynchronisation therapy with or without a defibrillator: individualising device prescription.
    Heart. 2022;108:1164-1166.
    PubMed    


    June 2022
  6. KUMAR R, Rai N, Ahmed AS
    Right heart failure in a young man.
    Heart. 2022;108:1120-1160.
    PubMed    


  7. KEENAN J, Pal J
    The need for speed: modulating left ventricular assist device flow in response to varying physiological conditions.
    Heart. 2022;108:996-997.
    PubMed    


  8. STAPOR M, Pilat A, Gackowski A, Misiuda A, et al
    Echo-guided left ventricular assist device speed optimisation for exercise maximisation.
    Heart. 2022;108:1055-1062.
    PubMed     Abstract available


  9. GIBLETT JP, Williams LK, Moorjani N, Calvert PA, et al
    Percutaneous management of paravalvular leaks.
    Heart. 2022;108:1005-1011.
    PubMed     Abstract available


  10. KWAN A, Demosthenes E, Salto G, Ouyang D, et al
    Cardiac microstructural alterations measured by echocardiography identify sex-specific risk for heart failure.
    Heart. 2022 Jun 9. pii: heartjnl-2022-320876. doi: 10.1136/heartjnl-2022-320876.
    PubMed     Abstract available


    May 2022
  11. PARWANI PJ, Van Spall HGC, Mamas M
    Representation of women in heart failure trials: does it matter?
    Heart. 2022 May 17. pii: heartjnl-2022-321094. doi: 10.1136/heartjnl-2022-321094
    PubMed    


  12. BHASIN D, Kumar R, Bansal S
    Man with recent myocardial infarction and heart failure.
    Heart. 2022;108:847-898.
    PubMed    


  13. KEENE D, Whinnett ZI
    Advances in cardiac resynchronisation therapy: review of indications and delivery options.
    Heart. 2022;108:889-897.
    PubMed    



  14. Correction: Heart failure medication dosage and survival in women and men seen at outpatient clinics.
    Heart. 2022 May 5. pii: heartjnl-2021-319229.
    PubMed    


  15. HAYDOCK P, Camm AJ
    History and evolution of pacing and devices.
    Heart. 2022;108:794-799.
    PubMed     Abstract available


    April 2022
  16. BUBER J, Robertson HT
    Cardiopulmonary exercise testing for heart failure: pathophysiology and predictive markers.
    Heart. 2022 Apr 11. pii: heartjnl-2021-319617. doi: 10.1136/heartjnl-2021-319617
    PubMed     Abstract available


  17. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    PubMed     Abstract available


    March 2022
  18. MORGAN H, Sinha A, Mcentegart M, Hardman SM, et al
    Evaluation of the causes of sex disparity in heart failure trials.
    Heart. 2022 Mar 31. pii: heartjnl-2021-320696. doi: 10.1136/heartjnl-2021-320696
    PubMed     Abstract available


  19. TAN ESJ, Oon YY, Chan SP, Liew OW, et al
    Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis.
    Heart. 2022 Mar 24. pii: heartjnl-2021-320707. doi: 10.1136/heartjnl-2021-320707
    PubMed     Abstract available


  20. TAKAYA Y, Akagi T, Sakamoto I, Kanazawa H, et al
    Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
    Heart. 2022;108:382-387.
    PubMed     Abstract available


  21. AYTON SL, Gulsin GS, McCann GP, Moss AJ, et al
    Epicardial adipose tissue in obesity-related cardiac dysfunction.
    Heart. 2022;108:339-344.
    PubMed     Abstract available


    February 2022
  22. IOANNOU A
    Unusual presentation of cardiogenic shock in a young patient.
    Heart. 2022;108:211-242.
    PubMed    


  23. PATEL D, Kumar A, Moennich LA, Trulock K, et al
    Cardiac resynchronisation therapy in anthracycline-induced cardiomyopathy.
    Heart. 2022;108:274-278.
    PubMed     Abstract available


  24. BHAGRA SK, Pettit S, Parameshwar J
    Implantable left ventricular assist device: indications, eligibility and current outcomes.
    Heart. 2022;108:233-241.
    PubMed    


  25. GREER C, Troughton RW, Adamson PD, Harris SL, et al
    Preterm birth and cardiac function in adulthood.
    Heart. 2022;108:172-177.
    PubMed     Abstract available


  26. AKHTAR AM, Ghouri N, Chahal CAA, Patel R, et al
    Ramadan fasting: recommendations for patients with cardiovascular disease.
    Heart. 2022;108:258-265.
    PubMed     Abstract available


    January 2022
  27. COHEN DJ, Wang K, Magnuson E, Smith R, et al
    Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation.
    Heart. 2022 Jan 25. pii: heartjnl-2021-320005. doi: 10.1136/heartjnl-2021-320005
    PubMed     Abstract available


  28. EMMONS-BELL S, Johnson C, Roth G
    Prevalence, incidence and survival of heart failure: a systematic review.
    Heart. 2022 Jan 18. pii: heartjnl-2021-320131. doi: 10.1136/heartjnl-2021-320131
    PubMed     Abstract available


  29. GEVAERT AB, Kataria R, Zannad F, Sauer AJ, et al
    Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management.
    Heart. 2022 Jan 12. pii: heartjnl-2021-319605. doi: 10.1136/heartjnl-2021-319605
    PubMed     Abstract available


  30. SOTOMI Y, Hikoso S, Komukai S, Sato T, et al
    Phenotyping of acute decompensated heart failure with preserved ejection fraction.
    Heart. 2022 Jan 5. pii: heartjnl-2021-320270. doi: 10.1136/heartjnl-2021-320270.
    PubMed     Abstract available


  31. OTTO CM
    Heartbeat: sex disparities in stroke, heart failure and all-cause mortality in adults with coronary heart disease.
    Heart. 2022;108:1-3.
    PubMed    


  32. GULSIN GS, Graham-Brown MPM, Squire IB, Davies MJ, et al
    Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases.
    Heart. 2022;108:16-21.
    PubMed     Abstract available


  33. TUTAREL O, Baris L, Budts W, Gamal Abd-El Aziz M, et al
    Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
    Heart. 2022;108:117-123.
    PubMed     Abstract available


    December 2021
  34. BROWNRIGG JR, Leo V, Rose J, Low E, et al
    Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study.
    Heart. 2021 Dec 30. pii: heartjnl-2021-320181. doi: 10.1136/heartjnl-2021-320181
    PubMed     Abstract available


  35. KAPLON-CIESLICKA A, Soloveva A, Mareev Y, Cabac-Pogorevici I, et al
    Hyponatraemia in heart failure: time for new solutions?
    Heart. 2021 Dec 13. pii: heartjnl-2021-320277. doi: 10.1136/heartjnl-2021-320277
    PubMed     Abstract available


  36. GUO X, Song R, Chen Y
    Severe aortic regurgitation and heart failure.
    Heart. 2021;107:1874-1924.
    PubMed    


  37. STEINER JM, Cooper S
    Building a career in cardiology and palliative care.
    Heart. 2021;107:1920-1921.
    PubMed    


    November 2021
  38. NEDKOFF L, Weber C
    Heart failure: not just a disease of the elderly.
    Heart. 2021 Nov 22. pii: heartjnl-2021-320273. doi: 10.1136/heartjnl-2021-320273
    PubMed    



  39. Correction: Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
    Heart. 2021;107:e15.
    PubMed    


  40. ZANDSTRA TE, Nederend M, Jongbloed MRM, Kies P, et al
    Sacubitril/valsartan in the treatment of systemic right ventricular failure.
    Heart. 2021;107:1725-1730.
    PubMed     Abstract available


    October 2021
  41. CHAN DZL, Kerr A, Grey C, Selak V, et al
    Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006-2018.
    Heart. 2021 Oct 22. pii: heartjnl-2021-319853. doi: 10.1136/heartjnl-2021-319853
    PubMed     Abstract available


  42. DEYELL MW, Hawkins NM
    Odd couple: premature ventricular contractions and heart failure.
    Heart. 2021 Oct 19. pii: heartjnl-2021-319986. doi: 10.1136/heartjnl-2021-319986
    PubMed    


  43. YALTA K, Ozkan U, Yalta T
    Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Joshi et al.
    Heart. 2021 Oct 16. pii: heartjnl-2021-320124. doi: 10.1136/heartjnl-2021-320124
    PubMed    


  44. JOSHI SS, Singh T, Singh J, Newby DE, et al
    Response to: Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Yalta et al.
    Heart. 2021 Oct 16. pii: heartjnl-2021-320174. doi: 10.1136/heartjnl-2021-320174
    PubMed    


  45. LV S, Wang Y, Zhang W, Shang H, et al
    Trimethylamine oxide: a potential target for heart failure therapy.
    Heart. 2021 Oct 5. pii: heartjnl-2021-320054. doi: 10.1136/heartjnl-2021-320054.
    PubMed     Abstract available


  46. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    PubMed     Abstract available


    September 2021
  47. RAMOS NASCIMENTO B, Zawacki Beaton A
    Improved standardisation of training needed to achieve the potential of handheld echocardiography.
    Heart. 2021 Sep 27. pii: heartjnl-2021-319945. doi: 10.1136/heartjnl-2021-319945
    PubMed    


  48. LIU Y, Tan N, Huo Y, Chen S, et al
    Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial.
    Heart. 2021 Sep 11. pii: heartjnl-2021-319716. doi: 10.1136/heartjnl-2021-319716
    PubMed     Abstract available


  49. LIMPITIKUL WB, Dewland TA, Vittinghoff E, Soliman E, et al
    Premature ventricular complexes and development of heart failure in a community-based population.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319473. doi: 10.1136/heartjnl-2021-319473.
    PubMed     Abstract available


  50. NASER JA, Pislaru S, Stan MN, Lin G, et al
    Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease.
    Heart. 2021 Sep 6. pii: heartjnl-2021-319752. doi: 10.1136/heartjnl-2021-319752.
    PubMed     Abstract available


  51. DOS-SUBIRA L
    Failing systemic right ventricle: to treat or not to treat.
    Heart. 2021;107:1360-1361.
    PubMed    


    August 2021
  52. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    PubMed     Abstract available


  53. HASSAN R, Ahmed SB
    Sex differences in heart failure and precision medicine: right patient, right time...wrong dose?
    Heart. 2021 Aug 18. pii: heartjnl-2021-319831. doi: 10.1136/heartjnl-2021-319831
    PubMed    


  54. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    PubMed     Abstract available


  55. SINGH A, Agarwal A, Wafford QE, Shah SJ, et al
    Efficacy and safety of diuretics in heart failure with preserved ejection fraction: a scoping review.
    Heart. 2021 Aug 2. pii: heartjnl-2021-319643. doi: 10.1136/heartjnl-2021-319643.
    PubMed     Abstract available


  56. RAMAKUMAR V, Arvind B, Deepti S
    A young man with acute heart failure and a holodiastolic murmur.
    Heart. 2021;107:1288-1356.
    PubMed    


    July 2021
  57. BOTS SH, Onland-Moret NC, Tulevski II, van der Harst P, et al
    Heart failure medication dosage and survival in women and men seen at outpatient clinics.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319229. doi: 10.1136/heartjnl-2021-319229
    PubMed     Abstract available


  58. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed     Abstract available


  59. MUDIGONDA P, Berardi C, Chetram V, Barac A, et al
    Implications of cancer prior to and after heart transplantation.
    Heart. 2021 Jul 1. pii: heartjnl-2020-318139. doi: 10.1136/heartjnl-2020-318139.
    PubMed     Abstract available


    June 2021
  60. TAYLOR CJ, Lay-Flurrie SL, Ordonez-Mena JM, Goyder CR, et al
    Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004-2018.
    Heart. 2021 Jun 28. pii: heartjnl-2021-319196. doi: 10.1136/heartjnl-2021-319196
    PubMed     Abstract available


  61. DOCHERTY KF, Petrie MC
    Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure.
    Heart. 2021 Jun 14. pii: heartjnl-2020-318658. doi: 10.1136/heartjnl-2020-318658
    PubMed    


  62. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed     Abstract available


  63. DESAI RJ, Patorno E, Vaduganathan M, Mahesri M, et al
    Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319405. doi: 10.1136/heartjnl-2021-319405.
    PubMed     Abstract available


  64. GRIFFIN J, Cheng R
    Real-world utilisation of angiotensin-neprilysin inhibitors in older adults with heart failure.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319545. doi: 10.1136/heartjnl-2021-319545.
    PubMed    


  65. MINNERS J, Jander N
    Consecutive, index and representative beats: obtaining reliable information despite an irregular heart rhythm.
    Heart. 2021;107:862-863.
    PubMed    


    May 2021
  66. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed     Abstract available


  67. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    PubMed     Abstract available


  68. DESJARDIN J, Leyde S, Davis J
    Weathering the perfect storm: management of heart failure in patients with substance use disorders.
    Heart. 2021 May 24. pii: heartjnl-2021-319103. doi: 10.1136/heartjnl-2021-319103
    PubMed    


  69. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    PubMed     Abstract available


  70. CHUA W, Fabritz L
    Heart failure in patients with atrial fibrillation: why it matters now more than ever.
    Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145
    PubMed    


  71. LADOUCEUR M, Segura de la Cal T, Gaye B, Valentin E, et al
    Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle.
    Heart. 2021 May 6. pii: heartjnl-2020-318787. doi: 10.1136/heartjnl-2020-318787.
    PubMed     Abstract available


    March 2021
  72. ROMAINE SPR, Denniff M, Codd V, Nath M, et al
    Telomere length is independently associated with all-cause mortality in chronic heart failure.
    Heart. 2021 Mar 31. pii: heartjnl-2020-318654. doi: 10.1136/heartjnl-2020-318654
    PubMed     Abstract available


  73. BOROVAC JA
    Neurohormones and death in systolic heart failure: keep your friends close, but your enemies closer.
    Heart. 2021 Mar 18. pii: heartjnl-2021-319153. doi: 10.1136/heartjnl-2021-319153
    PubMed    


  74. AIMO A, Prontera C, Passino C, Emdin M, et al
    Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failure.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318791. doi: 10.1136/heartjnl-2020-318791
    PubMed     Abstract available


  75. WEBER C, Hung J, Hickling S, Nedkoff L, et al
    Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation.
    Heart. 2021 Mar 11. pii: heartjnl-2020-318648. doi: 10.1136/heartjnl-2020-318648
    PubMed     Abstract available


  76. BUNTING KV, Gill SK, Sitch A, Mehta S, et al
    Improving the diagnosis of heart failure in patients with atrial fibrillation.
    Heart. 2021 Mar 10. pii: heartjnl-2020-318557. doi: 10.1136/heartjnl-2020-318557
    PubMed     Abstract available


  77. GUASCH E
    Natriuretic peptides in atrial fibrillation: evidence is here, but are we ready to go one step beyond?
    Heart. 2021 Mar 9. pii: heartjnl-2020-318335. doi: 10.1136/heartjnl-2020-318335.
    PubMed    


    February 2021
  78. JOSHI SS, Singh T, Newby DE, Singh J, et al
    Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
    Heart. 2021 Feb 26. pii: heartjnl-2020-318060. doi: 10.1136/heartjnl-2020-318060
    PubMed     Abstract available


  79. LADOUCEUR M
    Heart failure in adults with congenital heart disease: a call for action.
    Heart. 2021 Feb 23. pii: heartjnl-2020-318757. doi: 10.1136/heartjnl-2020-318757
    PubMed    


  80. NISHIKAWA Y, Fukahori H, Mizuno A, Kwong JS, et al
    Cochrane corner: advance care planning for adults with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-318458. doi: 10.1136/heartjnl-2020-318458
    PubMed    


  81. YAMAMOTO S, Yamaga T, Kawachi S, Shibuya M, et al
    Cochrane corner: Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-317888. doi: 10.1136/heartjnl-2020-317888
    PubMed    


    January 2021
  82. WU J, Hall AS, Gale CP
    Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Heart. 2021 Jan 15. pii: heartjnl-2020-316823. doi: 10.1136/heartjnl-2020-316823
    PubMed     Abstract available


  83. MOHEBALI D, Kittleson MM
    Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318062. doi: 10.1136/heartjnl-2020-318062
    PubMed     Abstract available


  84. YANDRAPALLI S, Malik A, Pemmasani G, Aronow W, et al
    Sex differences in heart failure hospitalisation risk following acute myocardial infarction.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318306. doi: 10.1136/heartjnl-2020-318306
    PubMed     Abstract available


  85. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Response to 'Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction'.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318849. doi: 10.1136/heartjnl-2020-318849.
    PubMed    


  86. ALBUQUERQUE LL, Meira E Cruz M, Salles C
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318762. doi: 10.1136/heartjnl-2020-318762.
    PubMed    


    December 2020
  87. BLACHER M, Zimerman A, Engster PHB, Grespan E, et al
    Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II.
    Heart. 2020 Dec 23. pii: heartjnl-2020-317984. doi: 10.1136/heartjnl-2020-317984
    PubMed     Abstract available


  88. BURSTEIN DS, Rossano JW, Griffis H, Zhang X, et al
    Greater admissions, mortality and cost of heart failure in adults with congenital heart disease.
    Heart. 2020 Dec 23. pii: heartjnl-2020-318246. doi: 10.1136/heartjnl-2020-318246
    PubMed     Abstract available


    November 2020
  89. HAMATANI Y, Iguchi M, Ueno K, Aono Y, et al
    Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
    Heart. 2020 Nov 20. pii: heartjnl-2020-317735. doi: 10.1136/heartjnl-2020-317735
    PubMed     Abstract available


  90. REARDON L, Lin J
    Advanced heart failure and transplant in congenital heart disease.
    Heart. 2020 Nov 13. pii: heartjnl-2019-316366. doi: 10.1136/heartjnl-2019-316366
    PubMed    


  91. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2020 Nov 6. pii: heartjnl-2020-317326. doi: 10.1136/heartjnl-2020-317326.
    PubMed     Abstract available


  92. DROZD M, Relton SD, Walker AMN, Slater TA, et al
    Association of heart failure and its comorbidities with loss of life expectancy.
    Heart. 2020 Nov 5. pii: heartjnl-2020-317833. doi: 10.1136/heartjnl-2020-317833.
    PubMed     Abstract available


  93. ZIMERMAN A, Rohde LE
    Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure.
    Heart. 2020 Nov 2. pii: heartjnl-2020-317977. doi: 10.1136/heartjnl-2020-317977.
    PubMed    


    October 2020
  94. EGBE A, Miranda W, Connolly H, Dearani J, et al
    Haemodynamic determinants of improved aerobic capacity after tricuspid valve surgery in Ebstein anomaly.
    Heart. 2020 Oct 29. pii: heartjnl-2020-317756. doi: 10.1136/heartjnl-2020-317756
    PubMed     Abstract available


  95. HUNG CL, Chao TF, Su CH, Liao JN, et al
    Income level and outcomes in patients with heart failure with universal health coverage.
    Heart. 2020 Oct 20. pii: heartjnl-2020-316793. doi: 10.1136/heartjnl-2020-316793
    PubMed     Abstract available


  96. MULDER BA, Rienstra M, Blaauw Y
    Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
    Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
    PubMed     Abstract available


  97. BHATIA HS, Nishimura M, Dickson S, Adler E, et al
    Clinical and echocardiographic outcomes in heart failure associated with methamphetamine use and cessation.
    Heart. 2020 Oct 5. pii: heartjnl-2020-317635. doi: 10.1136/heartjnl-2020-317635.
    PubMed     Abstract available


  98. KAPLON-CIESLICKA A, Lund LH
    Atrial fibrillation in heart failure with preserved ejection fraction: a risk marker, risk factor or confounder?
    Heart. 2020 Oct 5. pii: heartjnl-2020-317978. doi: 10.1136/heartjnl-2020-317978.
    PubMed    


  99. MOCERI P, Lopez S, Ferrari E
    Atypical right heart failure in a septuagenarian.
    Heart. 2020;106:1524-1536.
    PubMed    


    September 2020
  100. BERGLUND F, Pina P, Herrera CJ
    Right ventricle in heart failure with preserved ejection fraction.
    Heart. 2020 Sep 7. pii: heartjnl-2020-317342. doi: 10.1136/heartjnl-2020-317342.
    PubMed     Abstract available


    August 2020
  101. PERRY AS, Mann DL, Brown DL
    Improvement of ejection fraction and mortality in ischaemic heart failure.
    Heart. 2020 Aug 25. pii: heartjnl-2020-316975. doi: 10.1136/heartjnl-2020-316975
    PubMed     Abstract available


  102. ZHANG X, Wang S, Liu J, Wang Y, et al
    D-dimer and the incidence of heart failure and mortality after acute myocardial infarction.
    Heart. 2020 Aug 12. pii: heartjnl-2020-316880. doi: 10.1136/heartjnl-2020-316880
    PubMed     Abstract available


  103. SCHRAGE B, Lund LH, Benson L, Stolfo D, et al
    Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure.
    Heart. 2020 Aug 7. pii: heartjnl-2020-317216. doi: 10.1136/heartjnl-2020-317216.
    PubMed     Abstract available


    July 2020
  104. AL-MOHAMMAD A
    NICE heart failure guidelines: the diagnostic algorithm in practice, what is the next step?
    Heart. 2020 Jul 20. pii: heartjnl-2020-317450. doi: 10.1136/heartjnl-2020-317450
    PubMed    


  105. ZHENG A, Cowan E, Mach L, Adam RD, et al
    Characteristics and outcomes of patients with suspected heart failure referred in line with National Institute for Health and Care Excellence guidance.
    Heart. 2020 Jul 20. pii: heartjnl-2019-316511. doi: 10.1136/heartjnl-2019-316511
    PubMed     Abstract available


  106. DARDAS T, Dorsch MP
    Remote management of heart failure: Herculean or Sisyphean task?
    Heart. 2020 Jul 9. pii: heartjnl-2020-317270. doi: 10.1136/heartjnl-2020-317270.
    PubMed    


    June 2020
  107. RAHIMI K, Nazarzadeh M, Pinho-Gomes AC, Woodward M, et al
    Home monitoring with technology-supported management in chronic heart failure: a randomised trial.
    Heart. 2020 Jun 24. pii: heartjnl-2020-316773. doi: 10.1136/heartjnl-2020-316773
    PubMed     Abstract available


  108. MARINI C, Fragasso G, Italia L, Sisakian H, et al
    Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure.
    Heart. 2020 Jun 22. pii: heartjnl-2019-316429. doi: 10.1136/heartjnl-2019-316429
    PubMed     Abstract available


  109. ROSANO G, Savarese G
    Inter-twinned relationship between heart failure and atrial fibrillation.
    Heart. 2020 Jun 1. pii: heartjnl-2020-316886. doi: 10.1136/heartjnl-2020-316886.
    PubMed    


    April 2020
  110. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    PubMed     Abstract available


  111. HONG SH, Lee JS, Kim JA, Lee YB, et al
    Gamma-glutamyl transferase variability and the risk of hospitalisation for heart failure.
    Heart. 2020 Apr 17. pii: heartjnl-2019-316271. doi: 10.1136/heartjnl-2019-316271
    PubMed     Abstract available


  112. OTTO CM
    Heartbeat: risk of stroke in patients with heart failure.
    Heart. 2020;106:549-551.
    PubMed    


    March 2020
  113. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available


  114. OTTO CM
    Heartbeat: can machine learning improve outcomes in patients with heart failure with preserved ejection fraction?
    Heart. 2020;106:315-317.
    PubMed    


  115. CHEN S, Banerjee A
    Machine learning: a long way from implementation in cardiovascular disease.
    Heart. 2020;106:318-320.
    PubMed    


    February 2020
  116. ERGATOUDES C, Hansson PO, Svardsudd K, Rosengren A, et al
    Comparison of incidence rates and risk factors of heart failure between two male cohorts born 30 years apart.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316059. doi: 10.1136/heartjnl-2019-316059
    PubMed     Abstract available


  117. CHEHAB O, Roberts-Thomson R, Ng Yin Ling C, Marber M, et al
    Secondary mitral regurgitation: pathophysiology, proportionality and prognosis.
    Heart. 2020 Feb 13. pii: heartjnl-2019-316238. doi: 10.1136/heartjnl-2019-316238
    PubMed     Abstract available


  118. BANERJEE A
    Ethnicity, heart failure and the prevention continuum: time to act.
    Heart. 2020 Feb 6. pii: heartjnl-2019-316293. doi: 10.1136/heartjnl-2019-316293.
    PubMed    


  119. BEGUE C, Morner S, Brito D, Hengstenberg C, et al
    Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Heart. 2020;106:196-202.
    PubMed     Abstract available


  120. TOBLER D, Greutmann M
    Simple cardiac shunts in adults: atrial septal defects, ventricular septal defects, patent ductus arteriosus.
    Heart. 2020;106:307-314.
    PubMed    


  121. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
    Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
    Heart. 2020;106:248-250.
    PubMed    


    January 2020
  122. NELSON AJ, Patel MR
    Ischaemic stroke in heart failure: back to basics?
    Heart. 2020 Jan 27. pii: heartjnl-2019-315957. doi: 10.1136/heartjnl-2019-315957
    PubMed    


  123. HEDMAN AK, Hage C, Sharma A, Brosnan MJ, et al
    Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning.
    Heart. 2020 Jan 7. pii: heartjnl-2019-315481. doi: 10.1136/heartjnl-2019-315481.
    PubMed     Abstract available


  124. GALLEGO P, Oliver JM
    Medical therapy for heart failure in adult congenital heart disease: does it work?
    Heart. 2020;106:154-162.
    PubMed    


    December 2019
  125. UEBERHAM L, Konig S, Hohenstein S, Mueller-Roething R, et al
    Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315566. doi: 10.1136/heartjnl-2019-315566
    PubMed     Abstract available


  126. OSTERGAARD L, Dahl A, Bruun NE, Oestergaard LB, et al
    Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure.
    Heart. 2019 Dec 10. pii: heartjnl-2019-315715. doi: 10.1136/heartjnl-2019-315715
    PubMed     Abstract available


  127. WOOD K, Gladwin M, Straub A
    Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure.
    Heart. 2019 Dec 10. pii: heartjnl-2019-314810. doi: 10.1136/heartjnl-2019-314810
    PubMed     Abstract available


    October 2019
  128. CHOU YL, Liou JT, Cheng CC, Tsai MC, et al
    The association of ischaemic stroke in patients with heart failure without atrial flutter/fibrillation.
    Heart. 2019 Oct 3. pii: heartjnl-2019-315646. doi: 10.1136/heartjnl-2019-315646.
    PubMed     Abstract available


  129. OTTO CM
    Heartbeat: oxygen transport close to and far from the ventricle in heart failure.
    Heart. 2019;105:1525-1527.
    PubMed    


    September 2019
  130. BERNARD S, Hung J
    Managing tricuspid valve regurgitation: a long and winding road.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315696. doi: 10.1136/heartjnl-2019-315696.
    PubMed    


    August 2019
  131. REDDY YNV, Nishimura R
    Intervening for tricuspid regurgitation: uncertainties in a heterogeneous syndrome.
    Heart. 2019 Aug 23. pii: heartjnl-2019-315624. doi: 10.1136/heartjnl-2019-315624
    PubMed    


  132. ZHANG H, El-Am EA, Thaden JJ, Pislaru SV, et al
    Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.
    Heart. 2019 Aug 22. pii: heartjnl-2019-314996. doi: 10.1136/heartjnl-2019-314996
    PubMed     Abstract available


  133. FROEHLICH L, Meyre P, Aeschbacher S, Blum S, et al
    Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315174. doi: 10.1136/heartjnl-2019-315174
    PubMed     Abstract available


    July 2019
  134. NEPPER-CHRISTENSEN L, Hofsten DE, Helqvist S, Lassen JF, et al
    Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.
    Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952
    PubMed     Abstract available


  135. CROSSLAND DS, Jansen K, Parry G, Harper A, et al
    Outcome following heart transplant assessment in adults with congenital heart disease.
    Heart. 2019 Jul 5. pii: heartjnl-2019-314711. doi: 10.1136/heartjnl-2019-314711.
    PubMed     Abstract available


    June 2019
  136. TAN ESJ, Tay WT, Teng TK, Richards AM, et al
    The diabetes-atrial fibrillation paradox.
    Heart. 2019;105:893.
    PubMed    


  137. GERDTS E, Saeed S, Midtbo H, Rossebo A, et al
    Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis.
    Heart. 2019 Jun 1. pii: heartjnl-2018-314462. doi: 10.1136/heartjnl-2018-314462.
    PubMed     Abstract available


    May 2019
  138. ONG G, Pibarot P
    Combined aortic stenosis and regurgitation: double the trouble.
    Heart. 2019 May 29. pii: heartjnl-2017-312303. doi: 10.1136/heartjnl-2017-312303
    PubMed    


    April 2019
  139. GALLAGHER C, Hendriks JM, Giles L, Karnon J, et al
    Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013.
    Heart. 2019 Apr 1. pii: heartjnl-2018-314471. doi: 10.1136/heartjnl-2018-314471.
    PubMed     Abstract available


    February 2019

  140. Correction: Heart rate: surrogate or target in the management of heart failure?
    Heart. 2019;105:e1.
    PubMed    


    December 2018
  141. NAKATSUMA K, Taniguchi T, Morimoto T, Shiomi H, et al
    B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis.
    Heart. 2018 Dec 7. pii: heartjnl-2018-313746. doi: 10.1136/heartjnl-2018-313746.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: